Clinical Trial Update: Phase 2 Study of the Safety, Tolerability and Pilot Efficacy of Oral Factor Xa Inhibitor Betrixaban Compared to Warfarin [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the safety, tolerability, and pilot efficacy of oral betrixaban versus warfarin for atrial fibrillation has completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Warfarin (warfarin)
• betrixaban (betrixaban)

Snippet

Sponsor: Portola Pharmaceuticals | Conditions: Atrial Fibrillation | Phase 2 | Status: COMPLETED | Results posted: 2017-09-26